CPC Scientific brings Peptide and Oligonucleotide CRDMO Leadership to major pharma events

Rocklin, CA – Global CPC Scientific Inc. will showcase its advanced Contract Research, Development, and Manufacturing Organization (CRDMO) capabilities for oligonucleotide and peptide development and manufacturing at a series of pharma and biotech events around the world during August and September 2026.

These include CPHI Korea from August 25, the early September 38th European Peptide Symposium in Vienna, the ChemOutsourcing pharma ingredients show and RNA Leaders USA Congress, both in Massachusetts in mid-September, and the Boulder Peptide Symposium in California, running from September 28 through to October 1.

CPC Scientific teams are accepting appointment bookings for face-to-face meetings at all five events (see Resources).

CPHI Korea

The annual CPHI Korea pharma and biotech industry fair in Seoul provides a dynamic meeting place where pharmaceutical suppliers, purchasers and decision makers get together for three days of business. Exhibiting companies showcase products from across the entire pharma supply chain: from ingredients and contract services, through to machinery and biopharmaceuticals.

CPC Scientific will exhibit from stand K27 at the COEX Convention & Exhibition Center, Seoul.

Schedule a meeting: CPHI Korea – CPC Scientific

38th European Peptide Symposium

The annual European Peptide Symposium is a leading conference for peptide science, encompassing cutting-edge synthetic methods, innovative technologies, computational tools, as well as structural and conformational studies, with a special emphasis on material, biological, and therapeutic applications.

The 2026 Symposium is a six-day event, opening September 6 at the Main Building, University of Vienna, with conference session taking place in the University’s main building Auditorium Maximum and the ‘Arkadenhof’.

Schedule a meeting: European Peptide Symposium – CPC Scientific

ChemOutsourcing

Running for three days from September 15, ChemOutsourcing is the premier CDMO USA-based pharmaceutical ingredients and services show for connecting global biologics manufacturing with hundreds of qualified buyers.

Focus areas for the 2026 conference include peptides, oligonucleotides, ADCs, and related biologics.

Schedule a meeting: ChemOutsourcing – CPC Scientific

RNA Leaders Congress

Less than a week after the ChemOutsourcing event ends, CPC Scientific will be back in Boston for the annual RNA Leaders USA Congress, the leading ‘must-attend’ event for genetic medicines such as RNAi, antisense, non-linear RNAs, RNA editing and targeting RNA, as well as manufacturing development of mRNA therapies and vaccines.

Boston’s Hynes Convention Center will host the three-day Congress, which features four simultaneous conference tracks covering in-depth development strategies, trends and technologies across the entire long and small RNA spectrum, including Analytics & Discovery, Next-Gen RNA, CMC & Scaling, and Oligo-based Therapeutics.

CPC Scientific will be located at Booth #23.

Schedule a meeting: RNA Leaders USA Congress – CPC Scientific

Boulder Peptide Symposium

Three days later, on America’s other coast, CPC Scientific will be a leading presence at the Boulder Peptide Symposium in California’s Napa Valley, as an exhibitor, leading sponsor and contributor to the conference agenda.

The Symposium is unique in being the only conference focused solely on the pharmaceutical development of peptide therapeutics, bringing together key decision leaders from both industry and academia to discuss future developments.

CPC Scientific is proud to be a Platinum Sponsor at BPS 2026! From September 28 – October 1, connect with us in Napa Valley, California to learn how our peptide & oligonucleotide CDMO capabilities can help accelerate your pipeline, from discovery through GMP manufacturing.

John Phipps, Vice President of Clinical Pipeline Development, will deliver a presentation on Day Two of the Symposium ‘Greener Process Innovations: Driving Sustainable, Scalable Peptide Manufacturing, which will explore how CPC Scientific strategic process design is accelerating sustainability, cost efficiency, and delivery timelines for greener peptide manufacturing at scale.

The presentation will include case studies illustrating how innovations are driving process efficiency and increased throughput for large-scale TIDES and GLP-1 production, while reducing environmental impact and production costs.

Schedule a meeting: Boulder Peptide Symposium – CPC Scientific

About CPC Scientific, Inc.

CPC Scientific is a premier global Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in synthetic peptides and oligonucleotides for the biopharmaceutical industry. Headquartered in Rocklin, California, CPC Scientific serves as the primary international corporate vehicle and strategic of Medtide Inc. (HKEX: 3880.HK), driving seamless global business operations and delivering access to an integrated infrastructure backed by nearly 25 years of technical excellence. The company supports pharmaceutical and biotechnology innovators through the most critical phases of drug development, with a particular focus on late-phase development, large-scale manufacturing, and commercial production.

Backed by metric-ton scale cGMP manufacturing, CPC Scientific operates world-class, cGMP-compliant commercial production facilities, including its core manufacturing asset in Hangzhou, China, which has successfully completed rigorous regulatory inspections conducted by multiple regulatory authorities and quality organizations, including the U.S. FDA, NMPA, TGA, and EMA, underscoring the company’s consistent compliance with international quality and manufacturing standards. To further strengthen global supply chain resilience and meet evolving market demands, CPC Scientific is actively expanding its global footprint with the development of a localized, state-of-the-art GMP manufacturing facility in the United States.

Learn more at: https://cpcscientific.com

Resources

See CPC Scientific Scheduled Events for further details and to book face-to-face meetings.